Free Notice to Take Deposition - District Court of Delaware - Delaware

Case 1 :06-cv-00033-SLR Document 73 Filed 11/17/2006 Page 1 of 4
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OP DELAWARE
TAKEDA PHARMACEUTICAL COMPANY, LTD.,
a Japanese Corporation, and
TAP PHARMACEUTICAL PRODUCTS, INC.,
a Delaware Corporation,
Plaintiffs and
Counterclaim~Defendants,
vs. Civii Action No. 06—3 3—SLR
TEVA PI-IARMACEUTICALS USA, INC.,
a Delaware corporation, and
TEVA PHARMACEUTICAL INDUSTRIES LTD.,
an Israeli Corporation,
Defendants and
Counterclaim~Plaintiffs.
TAKEDA PHARMACEUTICAL COMPANY, LTD.’s
RULE 30(h)(6) NOTICE OF DEPOSITION TO
TEVA PHARMACEUTICALS USA, INC. AND
TEVA PHARMACEUTICAL INDUSTRIES LTD.
PLEASE TAKE NOTICE that, pursuant to Ruie 30 of the Federal Rules of Civil
Procedure, Plaintiff Takeda Phmrnaceutical Company, Ltd. (“Tal attorneys, wilt take the depositions upon oral examination of Defendants Teva Pharmaceuticals
USA, Inc. and Teva Pharmaceutical Industries Ltd. (individually and coiiectively “Teva") 'oefore
a notary public or other officer authorized `oy law to administer oaths, at the offices of Hogan &
Hartson, LLP., 875 Third Avenue, New York, NY 10022, or at such other time and place as the
parties agree, commencing on December 20, 2006, and continuing day—to-day thereafter until
completed.

Case 1 :06-cv-00033-SLR Document 73 Filed 11/17/2006 Page 2 ot 4
PLEASE TAKE FURTHER NOTICE that, pursuant to Rule 30(b)(6) of the Federal
Rules of Civil Procedure, Teva is required to designate and produce for deposition one or more
officers, directors, or managing agents, or other persons who consent to testify on their behalf,
who shall testify as to matters known or reasonably available to Teva concerning each ofthe
matters listed on Schedule A hereto, By December 6, 2006, Teva should inform Takeda of the
person(s) designated to testify on its behalf with respect to these matters and specify the matters
on which each person will testify.
PLEASE TAKE FURTHER NOTICE that, pursuant to Rule 30(b)(2) ofthe
Federal Rules of Civil Procedure, the method by which testimony shall be recorded will be by
stenographic transcription and/or by videotape. You are invited to attend and eross—examine.
The Definitions and Instructions set forth in Plaintiffs Takeda Pharmaceutical
Company, Ltd.’s and TAP Pharmaceutical Products, Incfs First Set of Requests to Defendant
Teva Pharmaceutical Products USA, inc. for the Production of Documents and Things are
incorporated herein by reference.
CONNOLLY BOVE LODGE & HUTZ, LLP
November 17, zoos sy; *\§,_•} r __ , , , , A ‘··, . p r `·ti., M.
Arthur G. Connell ill (# `t• ` t·-t.,: `
The Nemours Building
3007 North Orange Street
P.O. Box 2207
Wilmington, DE i980l
(302) 658-9141
Attorneys for Plaintiff
Takeda Pharmaceutical Company, Ltd
2

Case 1 :06-cv-00033-SLR Document 73 Filed 11/17/2006 Page 3 of 4
Of Counsel: -
Eric J. Lobenfeld
Tedd W. Van Bus1 Arlene L. Chow
HOGAN & HARTSON L.L.P.
875 Third Avenue
New York, NY 10022
(212) 918-3000
Philippe Y. Riesen
HOGAN & I-IARTSON L.L.P.
Shinjuku Center Building, 46111 Floor
25-1 Nishi-Sbinjuku l~chome
Shinjuku, Tokyo 163-0646
Japan
(81) $-5908-0470
3

Case 1 :06-cv-00033-SLR Document 73 Filed 11/17/2006 Page 4 of 4
CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on November 17, 2006, I electronically filed the foregoing
document with the Clerk of the Court using CM/EC? which will send notification of such tiling
to the following counsel of record:
Karen L. Pascale, Esq.
Young Conaway Stargatt & Taylor LLP
The Brandywine Building
1000 West St., l"/th Floor
Wilmington, DE 19899 1
John L. North, Esq.
Jeffrey J. Toney, Esq.
John D. I-Iamann, Esq.
Sutherland Asbill & Brennan LLP
999 Peachtree Street
Atlanta, Georgia 30309-3996
JJJJ rrtrl, la., , ,./. 7»fr, risl 1 `rct·~/.
Arthur G. Connolly, (#266 l i`l—..g
#44524lml